| Literature DB >> 34174868 |
Afrin Iqbal1, Karar Zunaid Ahsan2, Kanta Jamil3, M Moinuddin Haider4, Shusmita Hossain Khan5, Nitai Chakraborty6, Peter Kim Streatfield4.
Abstract
BACKGROUND: Bangladesh is well advanced in the epidemiologic transition from communicable to noncommunicable diseases, which now account for two out of three deaths annually. This paper examines the latest nationally representative hypertension prevalence estimates, awareness, treatment, and control-to identify their association with potential correlates.Entities:
Keywords: Awareness; Blood pressure; Demographic health survey; Hypertension; Noncommunicable diseases
Year: 2021 PMID: 34174868 PMCID: PMC8235611 DOI: 10.1186/s12889-021-11234-5
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Conceptual Framework
Background characteristics of the study participants
| All | Male | Female | |
|---|---|---|---|
| 18–24 | 20.3 (2590) | 15.9 (879) | 23.6 (1712) |
| 25–34 | 24.9 (3175) | 21.9 (1214) | 27.1 (1961) |
| 35–44 | 20.2 (2573) | 21.6 (1190) | 19.1 (1383) |
| 45–54 | 14.1 (1796) | 15.5 (856) | 12.9 (939) |
| 55–64 | 11.3 (1439) | 12.7 (700) | 10.2 (738) |
| 65+ | 9.4 (1196) | 12.4 (682) | 7.1 (515) |
| Urban | 27.5 (3509) | 28.2 (1559) | 26.9 (1950) |
| Rural | 72.5 (9260) | 71.8 (3962) | 73.1 (5298) |
| Poorest | 19.0 (2430) | 18.4 (1014) | 19.5 (1416) |
| Poorer | 19.5 (2493) | 19.6 (1079) | 19.5 (1414) |
| Middle | 20.4 (2606) | 20.8 (1150) | 20.1 (1456) |
| Richer | 19.8 (2527) | 20.2 (1113) | 19.5 (1414) |
| Richest | 21.3 (2713) | 21. (1165) | 21.4 (1548) |
| No education | 25.4 (3238) | 23.2 (1282) | 26.9 (1956) |
| Primary | 29.9 (3826) | 31.3 (1727) | 28.9 (2099) |
| Secondary | 25.9 (3308) | 22.4 (1239) | 28.6 (2069) |
| College or higher | 18.8 (2397) | 23.1 (1273) | 15.5 (1124) |
| Underweight | 17.1 (2183) | 19.8 (1093) | 15.0 (1090) |
| Normal | 58.6 (7481) | 62.7 (3459) | 55.5 (4022) |
| Overweight and Obese | 24.3 (3105) | 17.6 (969) | 29.5 (2136) |
| No | 84.4 (10,777) | 83.1 (4587) | 85.4 (6190) |
| Yes | 9.3 (1182) | 9.7 (537) | 8.9 (645) |
| Not tested | 6.3 (810) | 7.2 (397) | 5.7 (413) |
Distribution of prevalence of hypertension, awareness, treatment and condition controlled, by explanatory variables
| Explanatory variables | Hypertensive | Aware | Treated | Controlled | ||||
|---|---|---|---|---|---|---|---|---|
| Percent | χ2 test | Percent | χ2 test p-value | Percent | χ2 test p-value | Percent | χ2 test p-value | |
| 18–24 | 8.5 | < 0.001 | 17.5 | < 0.001 | 12.3 | < 0.001 | 10.3 | 0.108 |
| 25–34 | 16.2 | 33.9 | 26.1 | 12.5 | ||||
| 35–44 | 28.5 | 37.8 | 32.4 | 12.8 | ||||
| 45–54 | 38.5 | 45.8 | 41.1 | 12.8 | ||||
| 55–64 | 46.7 | 53.4 | 48.5 | 15.9 | ||||
| 65+ | 54.4 | 48.0 | 42.8 | 9.2 | ||||
| Male | 26.0 | 0.004 | 33.4 | < 0.001 | 28.5 | < 0.001 | 9.0 | < 0.001 |
| Female | 28.2 | 48.8 | 42.9 | 15.0 | ||||
| Urban | 28.2 | 0.015 | 46.8 | < 0.001 | 41.5 | < 0.001 | 14.9 | 0.009 |
| Rural | 26.9 | 40.7 | 35.2 | 11.6 | ||||
| Poorest | 23.5 | < 0.001 | 32.3 | < 0.001 | 27.5 | < 0.001 | 8.9 | 0.001 |
| Poorer | 24.8 | 36.5 | 30.3 | 10.1 | ||||
| Middle | 26.5 | 41.7 | 37.4 | 12.0 | ||||
| Richer | 28.0 | 46.2 | 39.9 | 15.1 | ||||
| Richest | 32.9 | 50.7 | 45.0 | 14.9 | ||||
| No education | 35.4 | < 0.001 | 43.2 | 0.120 | 38.9 | 0.159 | 10.6 | 0.050 |
| Primary | 26.9 | 44.2 | 37.8 | 13.5 | ||||
| Secondary incomplete | 22.7 | 39.9 | 35.5 | 13.2 | ||||
| Secondary complete or higher | 23.2 | 41.2 | 33.6 | 13.8 | ||||
| Underweight | 17.7 | < 0.001 | 31.1 | < 0.001 | 26.2 | < 0.001 | 8.4 | 0.006 |
| Normal | 23.9 | 40.0 | 35.2 | 11.8 | ||||
| Overweight/Obese | 42.2 | 49.1 | 42.6 | 14.7 | ||||
| No | 25.4 | < 0.001 | 39.7 | < 0.001 | 34.1 | < 0.001 | 11.9 | 0.043 |
| Yes | 45.5 | 57.3 | 52.9 | 14.6 | ||||
| Not tested | 25.6 | 40.6 | 34.0 | 15.2 | ||||
Note 1: When chi-square tests were performed to see the proportional differences between the outcome variables and explanatory variables, they were significant except- education and aware; education and treated, age category and controlled
Note 2: The relatively high non-response rate among the study respondents (any males and females aged 18 years or more) was random in nature and did not distort the outcome variable estimates
Fig. 2Level of awareness, treatment and control among hypertensive adult population of 18 years or more
Adjusted odds ratios (AORs) for being hypertensive, aware, treated and controlled by explanatory variables
| Adjusted Odds Ratios (95% Confidence Interval) | ||||
|---|---|---|---|---|
| Explanatory variables | Hypertensive | Aware | Treated | Controlled |
| 18–24 | 0.26 (0.22–0.32)** | 0.39 (0.25–0.60)** | 0.33 (0.20–0.54)** | 0.77 (0.44–1.34) |
| 25–34 | 0.47 (0.40–0.54)** | 0.80 (0.61–1.06) | 0.70 (0.52–0.95)* | 0.88 (0.59–1.30) |
| 35–44 | (ref) | (ref) | (ref) | (ref) |
| 45–54 | 1.74 (1.48–2.05) ** | 1.49 (1.16–1.93)** | 1.55 (1.19–2.02)** | 1.04 (0.74–1.46) |
| 55–64 | 2.85 (2.46–3.30) ** | 2.47 (1.94–3.14)** | 2.51 (1.96–3.22)** | 1.57 (1.13–2.19)* |
| 65+ | 4.52 (3.82–5.35) ** | 2.38 (1.84–3.09)** | 2.37 (1.81–3.11)** | 0.93 (0.64–1.37) |
| Male | (ref) | (ref) | (ref) | (ref) |
| Female | 1.32 (1.20–1.46)** | 2.30 (1.94–2.73)** | 2.25 (1.89–2.68)** | 2.01 (1.56–2.58)** |
| Urban | (ref) | (ref) | (ref) | (ref) |
| Rural | 1.00 (0.88–1.13) | 0.94 (0.77–1.14) | 0.90 (0.75–1.09) | 0.88 (0.68–1.14) |
| Poorest | (ref) | (ref) | (ref) | (ref) |
| Poorer | 1.03 (0.86–1.22) | 1.29 (0.97–1.72)† | 1.23 (0.92–1.64) | 1.15 (0.76–1.76) |
| Middle | 1.03 (0.88–1.22) | 1.49 (1.12–1.98)* | 1.57 (1.19–2.07)* | 1.33 (0.85–2.09) |
| Richer | 1.08 (0.90–1.29) | 1.77 (1.32–2.37)** | 1.73 (1.31–2.30)** | 1.63 (1.09–2.45)* |
| Richest | 1.10 (0.91–1.32) | 1.81 (1.32–2.46)** | 1.83 (1.35–2.47)** | 1.43 (0.93–2.18) |
| No education | (ref) | (ref) | (ref) | (ref) |
| Primary | 1.08 (0.95–1.23) | 1.32 (1.08–1.61)* | 1.21 (0.98–1.48)† | 1.42 (1.07–1.90)* |
| Secondary incomplete | 1.15 (0.99–1.34)† | 1.18 (0.92–1.51) | 1.20 (0.93–1.55) | 1.38 (0.97–1.97)† |
| Secondary complete or higher | 1.17 (0.99–1.40)† | 1.42 (1.06–1.91)* | 1.25 (0.92–1.68) | 1.65 (1.12–2.43)* |
| Underweight | (ref) | (ref) | (ref) | (ref) |
| Normal | 1.82 (1.60–2.07)** | 1.52 (1.18–1.96)* | 1.58 (1.20–2.07)* | 1.27 (0.85–1.90) |
| Overweight and Obese | 4.37 (3.70–5.16)** | 1.99 (1.50–2.63)** | 1.96 (1.45–2.64)** | 1.31 (0.86–1.99) |
| No | (ref) | (ref) | (ref) | (ref) |
| Yes | 1.52 (1.31–1.78)** | 1.58 (1.27–1.96)** | 1.67 (1.36–2.08)** | 1.09 (0.82–1.46) |
| Not tested | 0.90 (0.74–1.10) | 0.97 (0.70–1.34) | 0.94 (0.66–1.34) | 1.24 (0.80–1.94) |
| Constant | 0.12 (0.09–0.15)** | 0.11 (0.07–0.17)** | 0.09 (0.06–0.14)** | 0. 1.24 (0.02–0.08)** |
**p < 0.001, * p < 0.05, † p < 0.10